Cart
sales@molnova.com
Endixaprine
CAS No. 93181-85-2
Endixaprine( —— )
Catalog No. M36108 CAS No. 93181-85-2
Endixaprine (SR 41378) is a small molecule compound used to treat neurological disorders and may be used to study anxiety disorders and epilepsy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 116 | Get Quote |
|
| 5MG | 168 | Get Quote |
|
| 10MG | 247 | Get Quote |
|
| 25MG | 466 | Get Quote |
|
| 50MG | 635 | Get Quote |
|
| 100MG | 884 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEndixaprine
-
NoteResearch use only, not for human use.
-
Brief DescriptionEndixaprine (SR 41378) is a small molecule compound used to treat neurological disorders and may be used to study anxiety disorders and epilepsy.
-
DescriptionEndixaprine (SR 41378) is a small molecule compound used to treat neurological disorders and may be used to study anxiety disorders and epilepsy.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number93181-85-2
-
Formula Weight324.21
-
Molecular FormulaC15H15Cl2N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClC1=C(C=CC(Cl)=C1)C2=CC=C(N=N2)N3CCC(O)CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MRS928
MRS928 is a bioactive chemical. It has a role as a plant metabolite. It derives from a galangin.
-
Gastrin-Releasing Pe...
Gastrin-releasing peptide is a regulatory human peptide that elicits gastrin release and regulates gastric acid secretion and enteric motor function. The post-ganglionic fibers of the vagus nerve that innervate the G cells of the stomach release GRP, which stimulates the G cells to release gastrin.
-
Licarbazepine
Licarbazepine is the pharmacologically active metabolite of oxcarbazepine a drug indicated for the treatment of partial seizures and bipolar disorders.
